|
Compound class:
Synthetic organic
Comment: CW-10201 is a PROTAC degrader for oncogenic KRAS proteins with G12V/D mutations [1]. It engages the cereblon E3 ligase (CRBN) using the novel high-sffinity, tetracyclic ligand AA-17010 to promote KRAS ubiquitination and proteasomal degradation. KRAS binding is mediated by a derivative of the non-covalent KRASG12D inhibitor MRTX1133.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Degrades KRASG12V and KRASG12D with DC50 values of ~4 nM [1]. The cereblon-binding moiety AA-17010, has a Ki of 80 nM, which is ~10 times higher affinity than lenalidomide. |
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||